SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
46 hedge funds and large institutions have $25M invested in Sorrento Therapeutics, Inc. in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 7 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
52% less capital invested
Capital invested by funds: $52.4M → $25M (-$27.5M)
59% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 29
Holders
46
Holding in Top 10
2
Calls
$13K
Puts
$9K
Top Buyers
| 1 | +$1.13M | |
| 2 | +$980K | |
| 3 | +$779K | |
| 4 |
Goldman Sachs
New York
|
+$502K |
| 5 |
ECM
Element Capital Management
New York
|
+$439K |
Top Sellers
| 1 | -$2.13M | |
| 2 | -$1.55M | |
| 3 | -$1.14M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$984K |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$674K |